Biopharmaceutical News and Research

RSS
CytRx sells global rights of molecular chaperone assets to Orphazyme

CytRx sells global rights of molecular chaperone assets to Orphazyme

17 May 2011
PGT, Quintiles collaborate to bring genomic testing into mainstream drug development

PGT, Quintiles collaborate to bring genomic testing into mainstream drug development

17 May 2011
China's SFDA approves TPI anti-diabetic drug Gliclazide

China's SFDA approves TPI anti-diabetic drug Gliclazide

13 May 2011
Sinovac first quarter sales increase 5.3% to $4.7 million

Sinovac first quarter sales increase 5.3% to $4.7 million

13 May 2011
Trillium raises $1 million to advance TTI-1612 into clinical trials for interstitial cystitis treatment

Trillium raises $1 million to advance TTI-1612 into clinical trials for interstitial cystitis treatment

12 May 2011
Miltenyi Biotec enters partnership with TeutoCell to develop novel cell culture techniques

Miltenyi Biotec enters partnership with TeutoCell to develop novel cell culture techniques

12 May 2011
CrystalGenomics receives draft CSR for CG400549 Phase I MAD study in Staph infections

CrystalGenomics receives draft CSR for CG400549 Phase I MAD study in Staph infections

12 May 2011
Santaris Pharma advances SPC4955 into Phase 1 trial for high cholesterol treatment

Santaris Pharma advances SPC4955 into Phase 1 trial for high cholesterol treatment

11 May 2011
ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

11 May 2011
Symphogen to present second-generation Sympress platform at ESACT conference

Symphogen to present second-generation Sympress platform at ESACT conference

11 May 2011
Naurex announces completion of $18 million Series A financing

Naurex announces completion of $18 million Series A financing

11 May 2011
U.S. biopharmaceutical companies to benefit from Almac's European Product Launch workshop

U.S. biopharmaceutical companies to benefit from Almac's European Product Launch workshop

11 May 2011
EMD Millipore inaugurates new Shanghai Biopharmaceutical Technical Center

EMD Millipore inaugurates new Shanghai Biopharmaceutical Technical Center

11 May 2011
Sosei acquires rights to Loramyc in Japan from BioAlliance Pharma

Sosei acquires rights to Loramyc in Japan from BioAlliance Pharma

11 May 2011
Micromet first quarter total revenues decrease to $5.5 million

Micromet first quarter total revenues decrease to $5.5 million

10 May 2011
Insmed first quarter revenues decrease to $1.6 million

Insmed first quarter revenues decrease to $1.6 million

10 May 2011
Tetraphase presents TP-434, TP-2758 antibiotics study data against pathogens at ECCMID

Tetraphase presents TP-434, TP-2758 antibiotics study data against pathogens at ECCMID

10 May 2011
Pepscan, Phylogica collaborate for Phylomer peptide lead optimisation

Pepscan, Phylogica collaborate for Phylomer peptide lead optimisation

10 May 2011
biocrea and Pfizer jointly presented details on novel PDE10 inhibitors

biocrea and Pfizer jointly presented details on novel PDE10 inhibitors

10 May 2011
UCSF scientists receive CIRM grants to advance degenerative muscle disease research

UCSF scientists receive CIRM grants to advance degenerative muscle disease research

10 May 2011

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback